Galapagos nv Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Galapagos nv Contact Number

Contact Galapagos

8 hours ago Glpg.com Get All

32 15 34Galapagos Corporate Headquarters. Galapagos NV Generaal De Wittelaan L11 A3 2800 Mechelen, Belgium Tel: +32 15 34 29 00 Fax: +32 15 34 29 01 VAT BE 0466.460.429

Website: https://www.glpg.com/contact

Category: Contact SupportShow more

Galapagos Overview, News & Competitors …

8 hours ago Zoominfo.com Get All

View contact profiles from Galapagos. SIC Code 28,283. NAICS Code 541711,62151. Ticker NASDAQ: GLPG. Show More. Popular Searches: Galapagos NV. Galapagos. Galapagos Genomics NV. Galapagos N.V. Galapagos Genomics. Drug Manufacturing & Research. Pharmaceuticals. Healthcare. What is Galapagos’s phone number? Galapagos’s phone number

Website: https://www.zoominfo.com/c/galapagos-nv/47287100

Category: Contact NumberShow more

Galapagos Crunchbase Company Profile & …

9 hours ago Crunchbase.com Get All

32 15 34Operating Status Active. Last Funding Type Post-IPO Equity. Legal Name Galapagos NV. Stock Symbol VIE:GLPG. Company Type For Profit. Contact Email [email protected] Phone Number +32 15 34 29 00. Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action

Website: https://www.crunchbase.com/organization/galapagos

Category: Contact NumberShow more

Contact Us Galapagos Conservancy, Inc.

5 hours ago Galapagos.org Get All

703.383.0077Headquarters: Galapagos Conservancy 11150 Fairfax Blvd, Suite 408 Fairfax, VA 22030. Phone: 703.383.0077. For information or questions about membership with Galapagos Conservancy, address changes, or mailing list removals, please send us an email.. For general inquiries and information, please use this email.. For media inquiries, please view our Media page and/or contact

Website: https://www.galapagos.org/about_us/about-us/contact-us/

Category: Contact SupportShow more

Galapagos NV BE 0466.460.429 Mechelen (2800)

1 hours ago Trendstop.knack.be Get All

466.460.429Consult contact data, management and financial key figures for Galapagos (BE 0466.460.429) from Mechelen (2800). Or for other companies in the sector Pharmaceutical industry.

Website: https://trendstop.knack.be/en/detail/466460429/galapagos.aspx

Category: Contact NumberShow more

Who we are Galapagos

1 hours ago Glpg.com Get All

Who we are. Galapagos NV discovers and develops small molecule medicines with novel modes of action, several of which show promising patient results and are currently in clinical development in multiple diseases. Our pipeline comprises discovery through to Phase 3 programs in inflammation, fibrosis, and other indications.

Website: https://www.glpg.com/who-are-we

Category: Contact NumberShow more

Galapagos NV Company Profile GlobalData

6 hours ago Globaldata.com Get All

Galapagos NV (Galapagos) is a biotechnology company that discovers and develops small molecule medicines for the treatment of inflammatory and fibrotic diseases. It offers Filgotinib medication targeting rheumatoid arthritis (RA). The company is investigating GLPG3667 compound against autoimmune indications; GLPG2737, a cystic fibrosis

Website: https://www.globaldata.com/company-profile/galapagos-nv/

Category: Contact NumberShow more

At a glance Galapagos Annual Report 2020

3 hours ago Reports.glpg.com Get All

The number of employees at 31 December 2020 includes 185 employees of Fidelta, which has been sold to Selvita on 4 January 2021. Employees per site Number of employees Galapagos

Website: https://reports.glpg.com/annual-report-2020/en/the-galapagos-group/at-a-glance.html

Category: Contact NumberShow more

Galapagos LLC

9 hours ago Galapagosllc.com Get All

Galapagos provides customers with world-class information technology solutions and services that are secure, reliable, scalable, flexible, and cost effective. We have ISO certifications in 9001 Quality Management, 20000-1 IT Service Management, and 27001 Information Security Management. We are a Native Hawaiian Owned SBA 8 (a) company.

Website: https://www.galapagosllc.com/

Category: Contact NumberShow more

Galapagos NV Wikipedia

2 hours ago En.wikipedia.org Get All

Galapagos NV (formerly known as Galapagos Genomics) is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.The CEO is the Dutchman Onno van de Stolpe.. The company develops drugs against rheumatoid …

Website: https://en.wikipedia.org/wiki/Galapagos_NV

Category: Contact NumberShow more

Remuneration policy for executive committee …

4 hours ago Reports.glpg.com Get All

Galapagos NV • Annual Report 2019. The remuneration of the CEO and of the other members of the executive committee consists of short-term and long-term remuneration. The short-term remuneration includes a fixed part, i.e. a base annual remuneration in cash, and a variable part, i.e. a cash bonus. The long-term incentives include the grant of

Website: https://reports.glpg.com/annual-report-2019/en/corporate-governance/remuneration-policy/remuneration-policy-for-executive-committee-members.html

Category: Contact NumberShow more

Share capital and shares Galapagos Annual …

7 hours ago Reports.glpg.com Get All

Share capital increases and issue of shares by Galapagos NV in 2019. On 1 January 2019, the share capital of Galapagos NV amounted to €294,599,712.11 represented by 54,465,421 shares. In the course of 2019 there were four capital increases resulting from the exercise of warrants under employee warrant plans, resulting in the issuance of

Website: https://reports.glpg.com/annual-report-2019/en/corporate-governance/share-capital-and-shares.html

Category: Contact NumberShow more

GLPG.AS Galapagos NV Profile Reuters

1 hours ago Reuters.com Get All

Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is focused on the discovery and development of small molecule medicines with novel modes of action. Its pipeline

Website: https://www.reuters.com/companies/GLPG.AS

Category: Contact NumberShow more

Welcome to Galapagos Conservancy Preserve, Protect

6 hours ago Galapagos.org Get All

May 25, 2021 “Extinct” for 112 Years: Galapagos Giant Tortoise Rediscovery Confirmed. May 19, 2021 NASA, Galapagos Conservancy Partner on Rewilding Galapagos Program. April 6, 2021 Galapagos Conservancy Awarded Top Rating for Efficiency, Accountability, and Transparency. From Our Blog. Rediscovering the Giant Tortoises and Magical

Website: https://www.galapagos.org/

Category: Contact NumberShow more

Galapagos Health

2 hours ago Galapagoshealth.com Get All

Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biopharmaceutical company, focused on the discovery, development and commercialization of innovative medicines that will improve people's lives.

Website: https://www.galapagoshealth.com/

Category: Contact NumberShow more

Galapagos NV Selective JAK1 Inhibitor …

5 hours ago Files.glpg.com Get All

Onno van de Stolpe - Galapagos NV - CEO Thank you, Elizabeth. It's a great pleasure to do the introduction of the DARWIN 1 final results. Before that, just a brief overview of Galapagos today, clearly, filgotinib, our flagship product looking forward in RA and other indications, but Galapagos is more than just filgotinib. We have a

Website: http://files.glpg.com/docs/website_1/DARWIN_1_W24_webcast_31_July_2015_transcript.pdf

Category: Contact NumberShow more

Galapagos NV (GLPG) Dividends

2 hours ago Dividendmax.com Get All

There are no Galapagos NV dividends. The chart below shows the optimized dividends for this security over a rolling 12-month period. Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of …

Website: https://www.dividendmax.com/netherlands/euronext-amsterdam/pharmaceuticals-and-biotechnology/galapagos/dividends

Category: Contact NumberShow more

Galapagos Company Profile Office Locations, …

6 hours ago Craft.co Get All

Galapagos has 1,489 employees across 6 locations and €478.05 M in annual revenue in FY 2020. See insights on Galapagos including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Website: https://craft.co/galapagos

Category: Contact NumberShow more

Galapagos Genomics BV Leiden, Netherlands

9 hours ago Bionity.com Get All

Show fax number. Show website. Darwinweg 24 2333 CR Leiden Netherlands. Request information now. Profile News & information On location . Galapagos is a drug discovery company with pre-clinical programs in bone and joint diseases and cachexia. Its division BioFocus DPI offers a full suite of target-to-drug discovery products and services to

Website: https://www.bionity.com/en/companies/14473/galapagos-genomics-bv.html

Category: Contact NumberShow more

Gilead and Galapagos Enter Into Transformative …

6 hours ago Gilead.com Get All

FOSTER CITY, Calif. & MECHELEN, Belgium -- (BUSINESS WIRE)--Jul. 14, 2019-- Gilead Sciences, Inc. (NASDAQ: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced that they have entered into a 10-year global research and development collaboration. Through this agreement, Gilead will gain access to an innovative portfolio of compounds

Website: https://www.gilead.com/news-and-press/press-room/press-releases/2019/7/gilead-and-galapagos-enter-into-transformative-research-and-development-collaboration

Category: Contact NumberShow more

A transition and execution year for Galapagos

2 hours ago Files.glpg.com Get All

15.49 15Galapagos share Number of shares issued on 31 December 30,299,129 29,794,046 26,770,747 Basic and diluted income / loss (–) per share (in €) 1.10 (0.28) (0.22) Dividend (in €) Share price on 31 December (in €) 15.49 15.30 15.81 Personnel data Total Group employees on 31 December (number) 417 8102 7962

Website: http://files.glpg.com/docs/website_1/annual_report_2014_EN.pdf

Category: Contact NumberShow more

ThromboGenics signs global and exclusive inlicensing

4 hours ago Oxurion.com Get All

Leuven, March 17 2016 – ThromboGenics NV (Euronext Brussels: THR), an integrated biopharmaceutical company focused on developing and commercializing innovative treatments for diabetic eye disease, today announces that it has signed a global and exclusive license agreement with Galapagos NV (Euronext & NASDAQ: GLPG) to develop and …

Website: https://www.oxurion.com/content/thrombogenics-signs-global-and-exclusive-licensing-agreement-galapagos-develop-and

Category: Contact NumberShow more

GALAPAGOS NV : GLPG Stock Price BE0003818359

1 hours ago Marketscreener.com Get All

Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is focused on the discovery and development of small molecule medicines with novel modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications.

Website: https://www.marketscreener.com/quote/stock/GALAPAGOS-NV-6464/

Category: Contact NumberShow more

Commercial Credit Report for Galapagos NV Report …

4 hours ago Info.creditriskmonitor.com Get All

Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is focused on the discovery and development of small molecule medicines with novel modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications.

Website: https://info.creditriskmonitor.com/Report/Snapshot.aspx?BusinessId=7859744

Category: Contact NumberShow more

Galapagos @ EULAR2021

2 hours ago Galapagosevents.com Get All

The EULAR European Congress of Rheumatology comprises the major event in the calendar of world rheumatology. The EULAR 2021 Virtual Congress will address a wide range of topics including clinical, translational and basic science. Galapagos is excited to be top sponsor at EULAR 2021 and to support two symposia and Meet the Expert session.

Website: https://www.galapagosevents.com/

Category: Contact NumberShow more

What Are Analysts and Indicators Saying About …

Just Now Baxterreport.com Get All

The total number of common shares currently owned by the public is 65.52 million. GLPG does have institutional investors; and they hold 9.99% of the stock. Galapagos NV – Insider Activity and Holdings. Currently, the stock has been recommended as Moderate Buy by 16 of the brokerage firms.

Website: https://baxterreport.com/2021/09/01/what-are-analysts-and-indicators-saying-about-galapagos-nv-glpg/

Category: Contact NumberShow more

Galapagos NV AnnualReports.com

Just Now Annualreports.com Get All

Galapagos NV. Galapagos (Euronext & NASDAQ: GLPG) is a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines with novel modes of action. Galapagos’ pipeline comprises Phase 3 through to discovery programs in cystic fibrosis, inflammation, fibrosis, osteoarthritis and other indications.

Website: https://www.annualreports.com/Company/galapagos-nv

Category: Contact NumberShow more

Galapagos and Gilead Announce Global Partnership to

6 hours ago Gilead.com Get All

646 254 3361Galapagos Webcast presentation of the partnership to be held on 17 December, 17.00 CET/ 11 AM EDT / 8 AM PST, +1 646 254 3361, access code 5852445, more call number info further down

Website: https://www.gilead.com/news-and-press/press-room/press-releases/2015/12/galapagos-and-gilead-announce-global-partnership-to-develop-filgotinib-for-the-treatment-of-rheumatoid-arthritis-and-other-inflammatory-diseases

Category: Contact NumberShow more

Galapagos NV, GLPG:AEX summary FT.com

4 hours ago Markets.ft.com Get All

Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is focused on the discovery and development of small molecule medicines with novel modes of action. Its pipeline comprises Phase 3, 2, 1, pre-c linical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications.

Website: http://markets.ft.com/data/equities/tearsheet/summary?s=GLPG:AEX

Category: Contact NumberShow more

Galapagos NV, GLPG:AEX profile FT.com

5 hours ago Markets.ft.com Get All

Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is focused on the discovery and development of small molecule medicines with novel modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications.

Website: https://markets.ft.com/data/equities/tearsheet/profile?s=GLPG:AEX

Category: Contact NumberShow more

We R.A. Priority – We R.A. Priority is a disease …

7 hours ago Werapriority.co.uk Get All

We R.A. Priority is a disease awareness programme that has been developed and paid for by Galapagos Biotech Ltd, a science-based pharmaceutical company with support from The National Rheumatoid Arthritis Society (NRAS).

Website: https://werapriority.co.uk/

Category: Contact NumberShow more

Galapagos and Merck & Co., Inc. agree to end …

7 hours ago Fiercebiotech.com Get All

32 2290 1791Click here to access the live audio webcast presentation at 11.00 CET (10.00 GMT), call number +32 2290 1791. CONTACT. Galapagos NV Onno van de Stolpe, CEO Tel: +31 6 2909 8028 begin_of_the

Website: https://www.fiercebiotech.com/biotech/galapagos-and-merck-co-inc-agree-to-end-strategic-alliances

Category: Contact NumberShow more

GLPG Stock Price Galapagos N.V. ADR Stock Quote …

8 hours ago Marketwatch.com Get All

Galapagos NV (GLPG) Q1 2021 Earnings Call Transcript May. 7, 2021 at 8:00 p.m. ET on Motley Fool Galapagos (GLPG) Gets a Buy Rating from Raymond James

Website: https://www.marketwatch.com/investing/Stock/GLPG

Category: Contact NumberShow more

Galapagos NV: Value Play, Or Value Trap? Sick …

2 hours ago Sickeconomics.com Get All

Despite these failures, some are saying that Galapagos could still be a worthwhile investment due to the possibility of a merger with a large pharmaceutical company. What Went Wrong? After seeing great success throughout 2019 and the beginning of 2020, Galapagos NV has left many of its investors feeling distraught in the past year.

Website: https://www.sickeconomics.com/2021/08/06/galapagos-nv-stock-performance/

Category: Contact NumberShow more

Galapagos Number of Employees 20132021 GLPG …

6 hours ago Macrotrends.net Get All

Galapagos number of employees from 2013 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Galapagos NV is a biotechnology company. The Company's operating segment consists of Research and Development and Services.

Website: https://www.macrotrends.net/stocks/charts/GLPG/galapagos/number-of-employees

Category: Contact NumberShow more

PieterPaul Strybol Researcher PhD Student …

6 hours ago Be.linkedin.com Get All

6 week internship in the field of bioinformatics at Galapagos. I successfully completed two projects: 1) dynamic visualization of a large meta-analysis in RShiny, 2) construct a textmining workflow with as goal the retrieval of a large number of PubMed articles related to a number of given keywords.

Title: Researcher PhD Student at …
Location: Ghent, Flemish Region, Belgium
Connections: 143

Website: https://be.linkedin.com/in/pieter-paul-strybol-801456158

Category: Contact NumberShow more

GALAPAGOS NV : Shareholders Board Members …

9 hours ago Marketscreener.com Get All

Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is focused on the discovery and development of small molecule medicines with novel modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications.

Website: https://www.marketscreener.com/quote/stock/GALAPAGOS-NV-6464/company/

Category: Contact NumberShow more

GLPG Galapagos NV ADR Stock Profile Barchart.com

1 hours ago Barchart.com Get All

Galapagos NV is a biotechnology company. The Company's operating segment consists of Research and Development and Services. Research and Development segment is engaged in the discovery and development of small molecules. Services segment offers drug discovery products and services. Its products include GLPG0634 for the treatment of rheumatoid

Website: https://www.barchart.com/stocks/quotes/GLPG/profile

Category: Contact NumberShow more

Galapagos : increases share capital through …

6 hours ago Marketscreener.com Get All

Galapagos issued 7,600 new ordinary shares on 20 September 2021, for a total capital increase (including issuance premium) of €151,787.50. Pursuant to the subscription right exercise program of Galapagos’ management board, members of the management board automatically are committed to exercise a minimum number of subscription rights

Website: https://www.marketscreener.com/quote/stock/GALAPAGOS-NV-6464/news/Galapagos-increases-share-capital-through-subscription-right-exercises-36470532/

Category: Contact NumberShow more

GLPG Galapagos NV • BioPharmCatalyst

5 hours ago Biopharmcatalyst.com Get All

Mechelen, Belgium; 30 August 2021, 22.01 CET; regulated information – Galapagos NV ((Euronext &, NASDAQ:GLPG) announces the planned retirement of CEO Onno van de Stolpe. Onno van de Stolpe co-founded Galapagos in 1999 and built and led the company as CEO from its early R&D days through to the commercial launch of Jyseleca ® (filgotinib) in Europe. . …

Website: https://www.biopharmcatalyst.com/company/glpg

Category: Contact NumberShow more

Contact our Travel Experts and get Free Online Travel

5 hours ago Galapagosislands.com Get All

Email. The best way to contact us is simply to complete our inquiry form. If you wish to email us directly, please email us at: [email protected] Quito Office Address. 265 Foch St. and 6 de Diciembre Ave., 3rd Floor, Sonelsa Tower. Quito - Ecuador. Postal code: 170143. USA Office Address.

Website: https://www.galapagosislands.com/agency/contact-us.html

Category: Contact SupportShow more

GALAPAGOS N.V. (GXE.BE) Stock Price, News, Quote & …

9 hours ago Finance.yahoo.com Get All

Galapagos reports H1 financial results with refocused pipeline and operational progress. First half-year 2021 financial results: Group revenues and other income of …

Website: https://finance.yahoo.com/quote/gxe.be/

Category: Contact NumberShow more

GALAPAGOS ANNOUNCES POSITIVE CHMP OPINION …

7 hours ago Finance.yahoo.com Get All

Mechelen, Belgium; 17 September 2021; 13.15 CET; Galapagos NV (Euronext & Nasdaq: GLPG) announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use

Website: https://finance.yahoo.com/news/galapagos-announces-positive-chmp-opinion-111500365.html

Category: Contact NumberShow more

Tom Van der Aa Clinical study leader Galapagos …

Just Now Be.linkedin.com Get All

Activity. Lieve, mooie, stoere Dian. Mijn rots in de branding! Wat een gaaf en herkenbaar stuk heb je geschreven #Maasstadziekenhuis #Stichtingook…. Liked by Tom Van der Aa. FirstWave is proud to be nominated as a Trends Gazellen Company for 2021. This last year has been challenging for everyone but thanks to our core….

Title: Clinical research professional
Location: Wachtebeke, Flemish Region, Belgium
1. 500+ connections

Website: https://be.linkedin.com/in/tom-van-der-aa-82b88016

Category: Contact NumberShow more

Jobs with Galapagos NV BioSpace

4 hours ago Biospace.com Get All

Galapagos increases share capital through subscription right exercises. 6/7/2021. Pursuant to the subscription right exercise program of Galapagos’ management board, members of the management board automatically are committed to exercise a minimum number of subscription rights, subject to certain conditions.

Website: https://www.biospace.com/employer/540921/galapagos-nv/

Category: Contact NumberShow more

Galapagos NV (GLPG) Q2 2021 Earnings Call Transcript …

9 hours ago Fool.com Get All

GLPG earnings call for the period ending June 30, 2021. Motley Fool Transcribers. (MFTranscribers) Aug 7, 2021 at 1:00AM. Image source: The Motley Fool. Galapagos NV ( NASDAQ:GLPG) Q2 2021

Website: https://www.fool.com/earnings/call-transcripts/2021/08/07/galapagos-nv-glpg-q2-2021-earnings-call-transcript/

Category: Contact NumberShow more

GLPG: Galapagos NV Stock Price Quote EN …

9 hours ago Bloomberg.com Get All

Galapagos NV is a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines with novel modes of action, with a …

Website: https://www.bloomberg.com/quote/GLPG:NA

Category: Contact NumberShow more

Gilead and Galapagos Announce New …

3 hours ago Gilead.com Get All

Contact. Global Operations and Association Code in connection with the term sheet that has been entered into between Gilead Sciences, Inc. and Galapagos NV on 15 December 2020. The return of the rights and responsibilities for filgotinib to Galapagos also comes with a number of challenges and risks in terms execution and operation, but

Website: https://www.gilead.com/news-and-press/press-room/press-releases/2020/12/gilead-and-galapagos-announce-new-commercialization-and-development-agreement-for-jyseleca-filgotinib

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What do you need to know about Galapagos NV?

Upgrade Your Profile and unlock all your annual reports. Galapagos (Euronext & NASDAQ: GLPG) is a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines with novel modes of action.

Who is the CEO of Galapagos NV?

Galapagos NV (formerly known as Galapagos Genomics) is a European pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel and Zagreb. The CEO is the Dutchman Onno van de Stolpe . The company develops drugs...

What kind of biotechnology company is Galapagos NV?

Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is focused on the discovery and development of small molecule medicines with novel modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications.

Where are the offices of the Galapagos company?

Galapagos has offices in Mechelen, Waltham, Zagreb, Romainville and in 2 other locations

Popular Brands

Godrej
Gbl
Geely
Gati
Gic
Gevo
Geron
Gaia
Gpa